Abstract
AML-664 A Tertiary Center's Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s2152-2650(23)01091-1
Journal: Clinical Lymphoma & Myeloma | Publication Date: Aug 31, 2023 |
AML-664 A Tertiary Center's Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Join us for a 30 min session where you can share your feedback and ask us any queries you have